Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H13NO3 |
Molecular Weight | 147.1723 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1CNC[C@@H](O)[C@@H]1O
InChI
InChIKey=QPYJXFZUIJOGNX-HSUXUTPPSA-N
InChI=1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m1/s1
Amicus Therapeutics was investigating afegostat (isofagomine; Plicera; HGT-3410; AT-2101), an orally available pharmacological chaperone molecule, which binds to glucocerebrosidase (Gba) and stimulates proper folding and trafficking of the enzyme, for the potential treatment of Parkinsons disease(PD) and Gaucher disease. Afegostat specifically and reversibly binds GCase in the ER with highaffinity; this stabilizes the active form of the enzyme in the ER and increases trafficking of GCase to lysosomes. In 2006, Orphan Drug designations were granted in the U.S. and E.U. in 2006 and 2007, respectively. However, this research has been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00446550
For the first 2 weeks, afegostat tartrate was administered orally at a dose of 225 milligrams (mg) once daily (QD) for 7 consecutive days, followed by no study medication for 7 consecutive days. After 2 weeks, participants then took 225 mg afegostat tartrate QD for 3 consecutive days, followed by no study medication for 4 consecutive days. This 3-days-on/4-days-off treatment regimen was followed for 22 weeks.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://medkoo.com/products/4459
Curator's Comment: Preincubation of purified glucocerebrosidase with afegostat (1 – 2.5 uM) increased the stability of the enzyme in a dose-dependent manner. https://www.ncbi.nlm.nih.gov/pubmed/18328804
Afegostat inhibits GCase with K(i) ~30 nM for wild-type and mutant enzymes (N370S and V394L)
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C87006
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL206468
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
169105-89-9
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
447607
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
TT-109
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
100000177265
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
Afegostat
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
C098432
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
DTXSID20168651
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
DB04545
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
m6487
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
C83520
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
9004
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY | |||
|
G23AP190YS
Created by
admin on Fri Dec 15 16:16:21 GMT 2023 , Edited by admin on Fri Dec 15 16:16:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)